What can we do to control the development of the fourth leading cause of blindness? Our latest whitepaper explores the affect our ageing population will have on cases of AMD, as well as other risk factors increasing incidence of the disease. We are likely to see double the number of cases in 2050 as we did in 2010, so we need to understand more about the risks.
Download our free whitepaper to read more about the development of AMD and key modifiable and non-modifiable risk factors. Key areas covered include:
- The academic case for targeted screening
- Lifestyle factors affecting AMD development
- Understanding wet and dry AMD
- What ophthalmologists can do
Download our whitepaper and share with your colleagues and peers.